E-LIB Suche - Ergebnisse für: Miners, John O.

1

Drug-drug interactions that alter the exposure of glucuroni..:

Miners, John O. ; Polasek, Thomas M. ; Hulin, Julie-Ann..
Pharmacology & Therapeutics. 248 (2023) - p. 108459 , 2023

Link: https://doi.org/10.1016/..

2

The molecular basis of dapsone activation of CYP2C9-catalyz..:

Nair, Pramod C. ; Burns, Kushari ; Chau, Nuy..
Journal of Biological Chemistry. 299 (2023) 12 - p. 105368 , 2023

Link: https://doi.org/10.1016/..

3

Inhibitory effects of non-steroidal anti-inflammatory drugs..:

Uchaipichat, Verawan ; Rowland, Andrew ; Miners, John O.
Drug Metabolism and Pharmacokinetics. 42 (2022) - p. 100442 , 2022

Link: https://doi.org/10.1016/..

4

Binding of SEP-363856 within TAAR1 and the 5HT1A receptor: ..:

Nair, Pramod C. ; Miners, John O. ; McKinnon, Ross A....
Molecular Psychiatry. 27 (2021) 1 - p. 88-94 , 2021

Link: https://doi.org/10.1038/..

5

Evidence-based strategies for the characterisation of human..:

Miners, John O. ; Rowland, Andrew ; Novak, Jonathan J...
Pharmacology & Therapeutics. 218 (2021) - p. 107689 , 2021

Link: https://doi.org/10.1016/..

6

Application of Model Informed Precision Dosing to Address t..:

Badaoui, Sarah ; Hopkins, Ashley M. ; Rodrigues, A David...
The AAPS Journal. 23 (2021) 1 - p. , 2021

Link: https://doi.org/10.1208/..

7

Binding of clozapine to the GABAB receptor: clinical and st..:

Nair, Pramod C. ; McKinnon, Ross A. ; Miners, John O..
Molecular Psychiatry. 25 (2020) 9 - p. 1910-1919 , 2020

Link: https://doi.org/10.1038/..

8

Inhibition of human UDP-glucuronosyltransferase (UGT) enzym..:

Korprasertthaworn, Porntipa ; Chau, Nuy ; Nair, Pramod C...
Biochemical Pharmacology. 169 (2019) - p. 113616 , 2019

Link: https://doi.org/10.1016/..

9

Identification of the caffeine to trimethyluric acid ratio ..:

van Dyk, Madelé ; Miners, John O. ; Marshall, Jean-Claude...
European Journal of Clinical Pharmacology. 75 (2019) 9 - p. 1211-1218 , 2019

Link: https://doi.org/10.1007/..

10

Relationship between vemurafenib plasma concentrations and ..:

Kichenadasse, Ganessan ; Hughes, Jim Henry ; Miners, John O....
Cancer Chemotherapy and Pharmacology. 85 (2019) 3 - p. 615-620 , 2019

Link: https://doi.org/10.1007/..

11

The inhibition selectivity of human UDP-glucuronosyltransfe..:

Miners, John O.
Drug Metabolism and Pharmacokinetics. 32 (2017) 1 - p. S20 , 2017

Link: https://doi.org/10.1016/..

12

A pragmatic, phase III, multisite, double-blind, placebo-co..:

Currow, David ; Watts, Gareth John ; Johnson, Miriam...
BMJ Open. 7 (2017) 7 - p. e018100 , 2017

Link: https://doi.org/10.1136/..

13

The human UDP-glucuronosyltransferase enzyme inhibition sel..:

Korprasertthaworn, Porntipa ; Rowland, Andrew ; Burns, Kushari...
Drug Metabolism and Pharmacokinetics. 32 (2017) 1 - p. S53 , 2017

Link: https://doi.org/10.1016/..

14

Response to in vitro and physiologically‐based pharmacokine..:

Miners, John O. ; Pattanawongsa, Attarat ; Rowland, Andrew
British Journal of Clinical Pharmacology. 84 (2017) 2 - p. 392-393 , 2017

Link: https://doi.org/10.1111/..

15

Advances in drug metabolism and pharmacogenetics research i..:

Mackenzie, Peter I. ; Somogyi, Andrew A. ; Miners, John O.
Pharmacological Research. 116 (2017) - p. 7-19 , 2017

Link: https://doi.org/10.1016/..